A study out of the University of Pennsylvania School of Nursing suggests that weight loss achieved through a combination of intensive behavioral therapy and 3 milligrams of liraglutide daily results in optimal weight-related quality of life for patients struggling with obesity.
Edwards Lifesciences announced Nov. 6 that it had received expanded CE mark approval in Europe for the use of its SAPIEN 3 transcatheter heart valve, a tool designed to facilitate TAVI in patients who don’t want to undergo open-heart surgery.
A novel risk calculator developed by researchers at the Cleveland Clinic encourages patients with both type 2 diabetes and obesity to weigh their treatment options for optimal long-term health.
The notion of a single-payer health system has been central to the 2020 presidential election, dominating much of the news cycle in recent months. According to an editorial published Nov. 4, that could be a good thing for physicians.
Here at CVB, we tend to think of our audience as cardiology’s practitioners, not its patients. But the truth is, the public is reading our content as frequently as physicians. Our job is the same, no matter the audience—to tell cardiology’s stories.
Remote monitoring and high-tech health management solutions have dominated cardiology headlines for the better part of the past year, touted for their accessibility and preventive benefits. But that vision of remote monitoring as the future of CV care might be a skewed representation of our current reality.
